Medicines in Iran have been put into the category of Priority-1 consumer goods, which is likely to lead to the state intervening in the control of prices with the aim of combatting inflation, reports the IRNA news agency.
Iran's Health Minister, Ali Reza Marandi, has announced the allocation of $420 million in foreign currency for the purchase medicines, together with dried milk and specialist equipment. he said 93% of the medicines used in Iran are produced domestically, and that Iran is one of the world's leading consumers of medicines.
Under a bill passed by the Majlis (parliament), the budget for Iranian hospitals and medical services is being made available to the health Ministry, and specialist services provided by the hospitals and services will become another source of income for them.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze